ClinConnect ClinConnect Logo
Search / Trial NCT06105723

An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults

Launched by THE UNIVERSITY OF HONG KONG · Oct 23, 2023

Trial Information

Current as of June 28, 2025

Recruiting

Keywords

Aging Functional Ability Care Model Community Dwelling

ClinConnect Summary

The Pathway to Healthy Aging (Path-HA) clinical trial is studying how a special program can help improve the health and daily functioning of older adults who may be experiencing signs of faster aging. The program lasts for 14 weeks and aims to enhance the quality of life for participants by addressing factors like physical activity, nutrition, and mental well-being. In this trial, older adults aged 60 and above, who have at least two risk factors for accelerated aging—such as trouble moving, feelings of loneliness, or sleep issues—are invited to participate.

Participants will be randomly assigned to either receive the Path-HA care program or be part of a control group that does not receive the program. Those who take part can expect to engage in health education activities designed to support their well-being. This trial is currently recruiting, and it’s open to all genders, focusing on community-dwelling individuals who can communicate effectively with the research team. If you or a loved one meets the eligibility criteria, this could be an opportunity to gain valuable support in aging healthily.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1) aged 60 or above,
  • 2) with at least two risk factors of accelerating aging defined as including reduced physical functioning, malnutrition, depressed mood, loneliness, poor health perception, and presence of geriatric symptoms (e.g. insomnia, pain, etc), based on their health screening results,
  • 3) community-dwelling,
  • 4) communicable to engage in health education activity.
  • Exclusion Criteria:
  • 1) any who is not at or at only one risk factor of accelerating aging,
  • 2) any who has problems in communicating with the research team.

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Doris Sau Fung YU, PhD

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported